AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06743126 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: ipilimumab
Description: in accordance with current respective prescribing information (PI) and/or summary of product characteristics (SmPC)
Study NCT06743126 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dacarbazine
Description: in accordance with current respective prescribing information (PI) and/or summary of product characteristics (SmPC)
Study NCT06743126 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: temozolomide
Description: in accordance with current respective prescribing information (PI) and/or summary of product characteristics (SmPC)
Study NCT06743126 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: paclitaxel
Description: in accordance with current respective prescribing information (PI) and/or summary of product characteristics (SmPC)
Study NCT06743126 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: paclitaxel plus carboplatin
Description: in accordance with current respective prescribing information (PI) and/or summary of product characteristics (SmPC)
Study NCT05267028 — intervention group
Intervention type: OTHER
Intervention: AD-TAR
Description: 12 sessions in groups of 4 subject, over 6 weeks (2 sessions per week), using a rehabilitation program named Training of Affect Recognition (TAR).
Study NCT05267028 — intervention group
Intervention type: OTHER
Intervention: AD-Cognitive Stimulation
Description: 12 sessions in groups of 4 subject, over 6 weeks (2 sessions per week), using classic cognitive stimulation workshops.
Study NCT05873530 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Grape
Description: Reconstituted whole grape powder
Study NCT05015751 — intervention group
Intervention type: DEVICE
Intervention: Thermal Anisotropy Measurement Device
Description: A wireless device for non-invasively assessing CSF shunt flow.
Study NCT05445180 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contingency management
Description: Contingency management will be used to encourage abstinence
Study NCT05937451 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: PRIME solution
Description: The investigators will apply an AKI prediction model (PRIME solution) based on the patient's demographic. The investigators will collect data on vital signs, laboratory test results, medication history, and surgical records. The investigators provide information on whether AKI develops within 48 hours and the top 10 explanatory factors for predicting AKI to the physician.
Study NCT05723250 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Table-based Educational Intervention
Description: Tablet based educational tool with videos about care coordination, cancer knowledge and self-advocacy.
Study NCT04674072 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reverse Nordic curl exercise
Description: The reverse Nordic curl is a body-weight exercise which mainly works the quadriceps and hip flexors. It has a large eccentric component, meaning the muscles are working whilst lengthening.
Study NCT04674072 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual warm up
Description: Usual warm up is defined as any basic exercises performed before a performance or practice to prepare the muscles for vigorous actions.
Study NCT05909358 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CAd3
Description: CAd3 candidate vaccine which is one of the investigational products
Study NCT05909358 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ChAdox1
Description: ChAdox1 candidate vaccine which is one of the investigational products
Study NCT05909358 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rVSV-SUDV
Description: rVSV-SUDV candidate vaccine which is one of the investigational products
Study NCT05909358 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Placebo
Study NCT04964973 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Post-surgical physiotherapeutic activity.
Study NCT04964973 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental
Description: Post-surgical physiotherapeutic activity with the application of the technique
Study NCT04964973 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Post-surgical physiotherapeutic activity with the application of the non-activated technique
Study NCT05676749 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: C-TIL051
Description: C-TIL051 given in combination with IL-15 (NKTR-255) and pembrolizumab
Study NCT05724394 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Culturally Adapted Getting Better Bite By Bite (Ca-GBBB) intervention
Description: The Ca-GBBB strongly focuses on enhancing participant's motivation and belief in their ability to change. The intervention will be comprised of 16-week training program delivered over four months.
Study NCT05398094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sotorasib
Description: AMG510 (Sotorasib) is small molecule that specifically and irreversibly inhibits the KRAS-G12C mutant protein. AMG510 (Sotorasib) finished product is presented as tablets containing 120mg and will be packaged in bottles of 120 tablets.
Study NCT04771871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epirubicin
Description: Epirubicin is an antitumor antibiotics with good activity on breast cancer. It has less cardiotoxic effect than doxorubicin
Study NCT04771871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Cyclophosphamide is a cytoxic drug indicated for the treatment of many malignancies including breast cancer
Study NCT04771871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Paclitaxel is a taxane chemotherapy agent indicated for the treatment of many cancers including breast cancer. It can be used alone or in combination with other drugs
Study NCT04771871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin is a platinum compound indicated for the treatment of many types of malignancies including breast cancer
Study NCT05159011 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: AGILITY (Access to Genetic Information Leveraging Innovative TechnologY)
Description: information about genetic testing through technology
Study NCT06487884 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: escape games
Description: A suitable day and time will be determined in the curriculum of the students in the intervention group and escape games consisting of various games involving intravenous drug administration will be played. Games will be played within the determined game guidelines. Each group will play the games at the stations respectively and get a clue at the end of each game. After completing the last game, the time it takes to find the password and complete the game will be recorded. After all groups complete the game, the group that completes the games in the shortest time will win the game and receive the prize in the chest.
Study NCT05610839 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance-Enhanced Behavior Therapy
Description: 8-module intervention delivering acceptance-enhanced behavior therapy through a fully automated website. This intervention was adapted from the Acceptance-enhanced behavior therapy workbook (Woods \& Twohig, 2008).
Study NCT05610839 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Acceptance-Enhanced Behavior Therapy
Description: 8-module intervention delivering acceptance-enhanced behavior therapy through a fully automated website. This intervention was adapted from the Acceptance-enhanced behavior therapy workbook (Woods \& Twohig, 2008).
Study NCT06158672 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotional freedom technique group
Description: Menopausal women in the emotional freedom technique group will be administered the emotional freedom technique by the researcher a total of 4 times at one week intervals.
Study NCT06158672 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Sham emotional freedom technique group
Description: Menopausal women in the sham emotional freedom technique group will be administered sham emotional freedom technique by the researcher a total of 4 times with one week intervals.
Study NCT04939896 — intervention group
Intervention type: OTHER
Intervention: observation
Description: Observed patients' compliance with rehabilitation at different time
Study NCT06623084 — intervention group
Intervention type: OTHER
Intervention: Platelets characterization
Description: To identify platelet features that correlate with liver disease progression and to study the mechanistic relationship between gut dysbiosis, metabolome composition, inflammation, and platelet activation in chronic liver disease.
Study NCT06492876 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: FT-003
Description: Administered via intraocular injection.
Study NCT05393050 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Colquhounia Root Tablet
Description: Colquhounia Root Tablet is a tripterygium preparation
Study NCT05393050 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methotrexate tablets
Description: Methotrexate is a drug used to treat rheumatoid arthritis
Study NCT05393050 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Methotrexate tablets
Description: Methotrexate is a drug used to treat rheumatoid arthritis
Study NCT05180422 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AMG 510
Description: Continuous once daily (QD) oral dosing (Days 1-21 each cycle) with or without food.
Study NCT05180422 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MVASI
Description: Intravenous (i.v.) infusion every 21 days (i.e. Day 1 of each 21-day cycle).
Study NCT05564091 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cataract surgery combined with ab-interno canaloplasty utililzing the iTrack Advance canaloplasty device
Description: 360 degree microcatheterization and viscodilation of Schlemm's canal
Study NCT05916066 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Nicotinamide
Description: Tabletts of 500mg Nicotinamide (B3-vitamin)
Study NCT05564091 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Cataract surgery
Description: Cataract surgery alone
Study NCT06743126 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Albumin-Bound Paclitaxel
Description: in accordance with current respective prescribing information (PI) and/or summary of product characteristics (SmPC)
Study NCT06745297 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 3776528
Description: BI 3776528
Study NCT06745297 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo matching BI 3776528
Description: Placebo matching BI 3776528
Study NCT06742294 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Movement education
Description: (1) providing preschool teachers professional development training in pedagogical knowledge and methods in the physical domain, (2) creating a set of teaching materials (in printed and digital formats) and methods that could be incorporated into the overall and preschool-based curricula, (3) creating a parental toolkit with contents mirroring the school materials, to enhance parents' knowledge and promote family-school collaboration, and (4) developing a smartphone-based artificial intelligence rating system to help preschool teachers conveniently and accurately assess children's motor skills, and provide appropriate instructional feedback.
Study NCT06742294 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Movement education
Description: (1) providing preschool teachers professional development training in pedagogical knowledge and methods in the physical domain, (2) creating a set of teaching materials (in printed and digital formats) and methods that could be incorporated into the overall and preschool-based curricula, (3) creating a parental toolkit with contents mirroring the school materials, to enhance parents' knowledge and promote family-school collaboration, and (4) developing a smartphone-based artificial intelligence rating system to help preschool teachers conveniently and accurately assess children's motor skills, and provide appropriate instructional feedback.
Study NCT06754189 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Time Limited stimulation
Description: The participant self-administer 30 min. of electrical stimulation using Time Limited stimulation to the dorsal genital nerve (DGN) for 6 weeks using UCon with the UCon-Patch electrode.
Study NCT06754189 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham stimulation
Description: The participant self-administer 30 min. of sham stimulation to the dorsal genital nerve (DGN) for 6 weeks using a sham device with the UCon-Patch electrode.
Study NCT06763016 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Theory-based group consultation
Description: The sessions focused on various topics, such as sexuality, sexual health, gender roles, and sexual violence. Participants were encouraged to engage in group discussions and complete weekly tasks, which allowed them to interact and reflect on the material presented. The intervention aimed to address and challenge prevalent sexual myths, encourage open discussions about sexuality, and foster healthier sexual attitudes through evidence-based counseling.~The content of the digital interventions was structured on the basis of a semi-structured interactive group counseling. It was supported by sharing content on Instagram, one of the most widely used social media tools of the generation representing.~For three days a week over six weeks, informative posts were shared, asynchronous testing and self-discovery activities were carried out, and a synchronous consultation session was held once a week. The participants were connected to the live broadcast of the research team.
Study NCT05257044 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabigerol
Description: Participants will ingest CBG and placebo in a double-blind randomized cross-over design
Study NCT05257044 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06758778 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: CreNeuroS CNS Fish Oil Plus Softgel [380 mg of fish oil contains Eicosapentaenoic Acid (EPA) （as EE）342 mg; L-5- Methyltetrahydrofolate 1.875 mg; other Vitamins and Minerals]
Description: Test product
Study NCT06758778 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vascepa® (Icosapent ethyl) 1000 mg Capsules, Deplin® (L-methylfolate Calcium) 7.5 mg Capsules
Description: Reference product
Study NCT06124339 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physical Activity
Description: There will be three sessions a week over the course of 16 weeks.
Study NCT06124339 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Activity (VR)
Description: There will be three sessions a week over the course of 16 weeks.
Study NCT06124339 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical and Cognitive Activity
Description: There will be three sessions a week over the course of 16 weeks.
Study NCT04721834 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Low-intensity Extracorporeal Shockwave Therapy
Description: Low intensity shockwave energy would be delivered to stimulate angiogenesis in corporal tissue. Therapy would be delivered through a linear probe in 6 sessions. It would be conducted as a day procedure.
Study NCT04721834 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Therapy
Description: Same device as the active treatment arm would be used, with the addition of sham probe which block all shockwaves.
Study NCT06779422 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pai.ACT
Description: The Pai.ACT mobile app is an innovative therapeutic tool that utilizes Acceptance and Commitment Therapy (ACT). It integrates a sophisticated algorithm to analyze self-reported data and conversation texts when the user interacts with the AI chatbot and identifies what psychological inflexibility processes are required to be the most essential to be addressed for process-matched ACT interventions. These interventions, including self-help modules and experiential exercises, are enhanced with dynamic animations and audio metaphors (see NCT06086951). The contents of Pai.ACT is underpinned by: (i) the core principles of Focused ACT, (ii) our validated Focused ACT protocol used in our ongoing Focused ACT trial (see NCT05803252), and (iii) our validated ACT protocols, established since 2019, that address psychological challenges specific to the Chinese parenting context (e.g., affiliate stigma, internalisation of external criticism, self-blame) through a 4-to-6 week of ACT.
Study NCT06779422 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Positive parenting advice
Description: Positive parenting advice is recommended by the Child Assessment Services under the Department of Health, and videoconferencing session(s) led by another experienced counsellor for content revision. No access to AI chatbot/ACT modules will be granted.
Study NCT06072261 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: kinesio tape application
Description: Before the standard rehabilitation program, kinesio taping was applied to both upper extremities in the form of a Y tape from the medial epicondyle to the wrist flexors, with 15-20% tension, to the patients hospitalized in the orthopedic service after lower extremity surgery. The tape should remain on the patient's arm throughout the hospital stay
Study NCT05099991 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Single Foley Balloon
Description: Foley Balloon will be placed through the cervix and inflated with 30mL of saline or water on the day prior to the procedure
Study NCT05099991 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Dilapan-S
Description: Dilapan S will be placed through the cervix on the day prior to the procedure
Study NCT05491642 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BAY3283142
Description: Oral administration
Study NCT05491642 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to BAY3283142
Description: Oral administration
Study NCT05253235 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SAAF
Description: A 7 session online intervention designed to augment protective processes associated with deterrence of substance use
Study NCT05253235 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Receipt of parenting book
Description: Parents will receive a copy of the book, Parenting for Liberation: A Guide for Raising Black Children
Study NCT05587374 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cadonilimab
Description: Cadonilimab 10mg/kg will be given every 3 weeks for 3 cycles in induction chemotherapy and for 14 cycles in adjuvant chemotherapy, started on day 1 of induction chemotherapy and adjuvant chemotherapy, respectively.
Study NCT05587374 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Gemcitabine 1g/m2, d1 \& 8 of every cycle, every 3 weeks for 3 cycles before radiation.
Study NCT05587374 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine
Description: Gemcitabine 1g/m2, d1 \& 8 of every cycle, every 3 weeks for 3 cycles before radiation.
Study NCT05587374 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Induction cisplatin 80mg/m2, every 3 weeks for 3 cycles before radiation; Concurrent cisplatin 100mg/m2, every 3 weeks for 2 cycles during radiation
Study NCT05587374 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: Induction cisplatin 80mg/m2, every 3 weeks for 3 cycles before radiation; Concurrent cisplatin 100mg/m2, every 3 weeks for 2 cycles during radiation
Study NCT05587374 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity-modulated radiotherapy
Description: Definitive intensity-modulated radiotherapy (IMRT) of 6996cGy will be given in 33 fractions.
Study NCT05587374 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Intensity-modulated radiotherapy
Description: Definitive intensity-modulated radiotherapy (IMRT) of 6996cGy will be given in 33 fractions.
Study NCT06508034 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo stool and blood sample collection
Study NCT06508034 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Live Freeze-Dried Lactic Acid Bacteria Probiotic
Description: Given PO
Study NCT06508034 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT05528133 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Genomically Guided Radiation Therapy
Description: Participants will receive treatment 5 days per week, in once daily fractions. The total dose will be 50 Gy in 25 fractions or 42.56 Gy in 16 fractions with or without a boost of 10 Gy in 5 fractions to the cavity.
Study NCT05507892 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: canagliflozin
Description: Canagliflozin is in a class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors. It is a used to treat type 2 diabetes. Canagliflozin lowers blood sugars by causing the kidneys to excrete more glucose in the urine.